俞募配穴埋线对肥胖型和非肥胖型多囊卵巢综合征患者性激素及胰岛素的影响

Influence on Sex Hormone and Insulin of Obese and Non Obese Patients with Polycystic Ovary Syndrome by Embedding Back-Shu and Front-Mu Points Association Catgut

目的研究俞募配穴埋线治疗对肥胖型和非肥胖型多囊卵巢综合征患者性激素及胰岛素的影响。方法选择年龄为14～39岁青春及育龄期患者60例,按照体质量指数（BMI）平均分为肥胖组（BMI≥25）和非肥胖组（BMI〈25）,采用俞募配穴埋线法治疗,观察两组患者治疗前后BMI、血睾酮（T）、黄体生成激素（LH）/卵泡刺激素（FSH）改善情况,并评价空腹及餐后2 h胰岛素（INS）、胰岛素抵抗稳态模型指数（HOMA-IR）、胰岛素抵抗改善情况。结果治疗后,仅肥胖组BMI较前下降,差异有统计学意义（P〈0.05）。两组治疗后T、LH/FSH、空腹INS、餐后2 h INS及HOMA-IR均较前下降,且差异均有统计学意义（P〈0.05）;两组疗效对比,差异无统计学意义（P〉0.05）。结论俞募配穴埋线能够有效地改善肥胖型及非肥胖型多囊卵巢综合征患者的性激素及胰岛素水平,同时能够有效减低肥胖型患者的BMI,而对非肥胖型患者体型无明显影响,值得临床推广应用。

Objective To study Back-Shu and Front-Mu points catgut embedding therapy for obese and non obese women with polycystic ovary syndrome patients with sex hormone and insulin. Methods Select the aged 14-39 patients and 60 cases of childbearing age. According to body mass index（BMI） were divided into obese group（BMI≥25kg/m^2） and non obesity group（BMI〈25 kg/m^2）. Using Back-Shu and Front-Mu points catgut embedding therapy. Two groups were observed with BMI, serum testosterone（T）, luteinizing hormone（LH） / follicle stimulating hormone （FSH） to improve the situation, and to evaluate the fasting and 2 hours after meal insulin（INS）, homeostasis model of insulin resistance（HOMA-IR） improvement. there was no significant change in BMI. The two groups the T, Results After treatment, BMI decreased in obesity group,and non obesity group LH/ FSH, the fasting and 2 h INS and HOMA-IR assessment all decreased. Comparison of the efficacy of two groups, the difference was not statistically significant. Conclusion Back-Shu and Front-Mu points catgut embedding method therapy can effectively improve the obese and non obese women with polycystic ovary syndrome in patients with sex hormone and insulin. It also can effectively reduce the obese patients with BMI, but had no obvious effect on the size of non obese patients, is worthy of clinical application.